Serious Science

Onsite Fungal Infection Diagnostic Laboratory

MiraVista Diagnostics operates a sophisticated onsite fungal infection diagnostic laboratory (fungal RL). It is the central feature of our new state-of-the-art corporate headquarters in Indianapolis, Indiana.

Certified, Focused + Specialized Fungal RL (Reference Lab)

MiraVista Diagnostics’ fungal RL (reference lab) is certified by CAP and CLIA. It is exclusively focused on processing diagnostic tests for serious fungal infections and specializes in a comprehensive menu of fungal antigen and antibody detection tests.

Our experienced clinical laboratory scientists handle, process and analyze over 100,000 diagnostic tests each year and our team of quality assurance specialists are responsible for our fungal infection diagnostic laboratory’s adherence to internal standard operating practices and compliance with industry regulations for infectious disease control, sample integrity, testing procedures, documentation, environmental responsibility and workplace safety.

 

COMPANY NEWS

NEW: MVista® Histoplasma Antibody IgG IgM EIA

Improve Diagnosis of Acute Pulmonary Histoplasmosis by Combining Antigen & Antibody Testing Review the technical specifications for the NEW MVista® Histoplasma Antibody IgG IgM EIA>> CLINICAL BACKGROUND Acute pulmonary histoplasmosis (APH) can be severe, especially following heavy exposure and is…
READ MORE →

BULLETIN: CSTE Revised Its Histoplasmosis Position Statement at the 2016 Annual Conference

The Council of State and Territorial Epidemiologists (CSTE) approved the Infectious Disease Committee’s revisions to the histoplasmosis position statement, “Standardized Surveillance Case Definition for Histoplasmosis” at the organization’s annual conference in Anchorage, Alaska on June 19-23, 2016. Review the revised…
READ MORE →

FEATURE: Diagnosing Histoplasmosis by Antigen Detection

FEATURED CASE REPORT FROM THE DESK OF: Lawrence Joseph Wheat, MD Medical Director, Founder & President of MiraVista Diagnostics Here is an important patient case report I’d like to share with colleagues about diagnosing histoplasmosis by antigen detection. I welcome…
READ MORE →

NEW: MVista® Coccidioides Antibody IgG IgM EIA

Improve Coccidioidomycosis Diagnosis with a New, More Sensitive, Anti-Coccidioides Antibody Enzyme Immunoassay CLINICAL BACKGROUND Coccidioidomycosis is endemic to the southwestern United States, northern Mexico and regions of Central and South America. Coccidioidomycosis often presents as community acquired pneumonia (CAP) and…
READ MORE →

MiraVista Diagnostics is Adding Jobs in Indianapolis to Meet Growing Market Demand

MiraVista Diagnostics is adding several new positions across all departments to meet growing market demand for its mycology diagnostic testing services. The scientific company is actively recruiting qualified candidates for research, medical laboratory, sales and technology positions in Indianapolis. Please…
READ MORE →

Dr. Joseph Wheat is Selected as the 2015 MMSA Billy Cooper Award Winner for His Contributions in Clinical Mycology

The Medical Mycological Society of the Americas selected MiraVista Diagnostics’ President, Founder and Medical Director, Lawrence Joseph Wheat, MD, as the 2015 MMSA Billy Cooper Award winner. This prestigious award is given to individuals with continuous outstanding or meritorious contributions in the…
READ MORE →

LEARN MORE
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo
  • vendor logo